CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 646,554	$ 535,608
Marketable securities	395,650	158,376
Accounts receivable - trade, net	673,915	787,071
Accounts Receivable from Sanofi	110,720	104,707
Accounts receivable from Bayer HealthCare	142,619	63,189
Inventories	120,317	70,354
Deferred tax assets	49,005	44,677
Prepaid expenses and other current assets	61,732	32,952
Total current assets	2,200,512	1,796,934
Marketable securities	453,443	389,891
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization	818,967	526,983
Deferred tax assets	263,081	231,878
Other assets	3,416	5,327
Total assets	3,739,419	2,951,013
Current liabilities:
Accounts payable and accrued expenses	337,976	250,896
Deferred revenue from Sanofi, current portion	13,368	12,815
Deferred revenue - other, current portion	57,604	34,185
Facility lease obligations, current portion	1,252	939
Total current liabilities	410,200	298,835
Deferred revenue from Sanofi	75,283	76,522
Deferred Revenue - other	114,339	107,677
Facility lease obligations	276,112	184,258
Convertible senior notes	287,950	320,315
Other long-term liabilities	23,747	11,330
Total liabilities	1,187,631	998,937
Stockholders' equity:
Preferred Stock	0	0
Additional paid-in capital	2,423,434	2,045,857
Retained earnings (accumulated deficit)	145,206	(92,692)
Accumulated other comprehensive income (loss)	26,895	(1,188)
Treasury stock	(43,849)	0
Total stockholders' equity	2,551,788	1,952,076
Total liabilities and stockholders' equity	3,739,419	2,951,013
Class A Stock
Stockholders' equity:
Common stock	2	2
Common Stock
Stockholders' equity:
Common stock	100	97
Treasury Stock
Stockholders' equity:
Total stockholders' equity	$ (43,849)	$ 0